Dassault Systemes Aktie
40,55EUR | 0,43EUR | 1,07% |
WKN DE: A3CRC5 / ISIN: FR0014003TT8
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 19 789 | 20 496 | 22 523 | 23 811 | 0 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,22 | 0,24 | 0,25 | 0,25 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 3 735 | 4 684 | 4 802 | 5 736 | 6 568 |
Summe Anlagevermögen | 9 229 | 9 535 | 9 459 | 8 887 | 8 978 |
Summe Aktiva | 12 964 | 14 219 | 14 261 | 14 623 | 15 546 |
Bilanz (in Mio. EUR) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 7 858 | 8 008 | 6 936 | 6 777 | 6 465 |
Summe Eigenkapital | 5 106 | 6 211 | 7 325 | 7 846 | 9 081 |
Summe Passiva | 12 964 | 14 219 | 14 261 | 14 623 | 15 546 |
Adresse
10, rue Marcel Dassault, 78140 Vélizy-Villacoublay | |
Telefon | +33 (1) 61-62-61-62 |
Internet | http://www.3ds.com |
Management
Anne Asensio
Vice President-Design Experience |
Anthony J. Costello
President-Patient Cloud |
Bernard Charlès
Executive Chairman |
Bruno Latchague
Senior EVP-Global Field American Operations |
Béatrix Martinez
Vice President-Investor Relations |
Catherine Dassault
Director |
Claire Biot
Vice President-Life Sciences Industry |
Dominique Florack
President |
Elisa Prisner
VP-Corporate Strategy & Platform Transformation |
Florence Hu Aubigny
Executive Vice President-Research & Development |
Florence Verzelen
EVP-Industry, Marketing & Sustainability |
Geneviéve B. Berger
Independent Non-Executive Director |
Grégory Abate
Secretary & Senior Executive Vice President |
Herve Andorre
Director |
Laurence Barthès
Executive VP, Chief People & Information Officer |
Laurence Daures-Lescourret
Lead Independent Director |
Marie-Hélène Habert-Dassault
Director |
Odile Desforges
Independent Director |
Olivier Ribet
Executive Vice President |
Pascal Daloz
Chief Executive Officer & Director |
Philippe Laufer
Executive Vice-President-Global Brands |
Rouven Bergmann
Chief Financial Officer & Executive Vice President |
Soumitra Dutta
Independent Director |
Stéphane Declée
Chief Executive Officer-ENOVIA |
Tanneguy de Fromont de Bouaille
Director |
Tarek A. Sherif
Chairman-Life Sciences & Healthcare |
Victoire de Margerie
VP-Corporate Equity, Marketing & Communications |
Xavier Cauchois
Independent Director |